Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Penta Valent TbkISX:PEVE 15 EBIT per Share is Rp as of . 20. GuruFocus rates ISX:PEVE with a GF Score™ of 15/100. The stock has 1 warning sign investors should review. Among 523 Healthcare Providers & Services companies, PT Penta Valent Tbk ranks worse than 191204.4% on this metric.
PT Penta Valent Tbk's EBIT per Share for the
six
months ended in . 20 was Rp0.00.
PT Penta Valent Tbk does not have enough years/quarters to calculate its EBIT per Share for the trailing twelve months (TTM) ended in . 20.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for PT Penta Valent Tbk's EBIT per Share or its related term are showing as below:
ISX:PEVE's 3-Year EBIT Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 12 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
PT Penta Valent Tbk (ISX:PEVE) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
PT Penta Valent Tbk EBIT per Share Related Terms
PT Penta Valent Tbk EBIT per Share Historical Data
* Premium members only.
The historical data trend for PT Penta Valent Tbk's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Penta Valent Tbk (ISX:PEVE) has a EBIT per Share of Rp as of . 20. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on PT Penta Valent Tbk and its competitors. According to the industry distribution chart, PT Penta Valent Tbk ranks #999999 out of 523 companies in the Healthcare Providers & Services industry.
Is PT Penta Valent Tbk's EBIT per Share too high?
PT Penta Valent Tbk's current EBIT per Share is Rp. Based on the distribution chart, PT Penta Valent Tbk ranks #999999 out of 523 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, PT Penta Valent Tbk has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does PT Penta Valent Tbk's EBIT per Share compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, PT Penta Valent Tbk ranks #999999 out of 523 companies for EBIT per Share. This places PT Penta Valent Tbk in the lower half of its industry. The industry median EBIT per Share is 12.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 12.00, based on 523 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on PT Penta Valent Tbk and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 12.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Penta Valent Tbk's current EBIT per Share is Rp. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Penta Valent Tbk stock overvalued right now?
PT Penta Valent Tbk (ISX:PEVE) has a current EBIT per Share of Rp. The current EBIT per Share is Rp. PT Penta Valent Tbk's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For PT Penta Valent Tbk (ISX:PEVE), the current EBIT per Share is Rp as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Penta Valent Tbk is engaged in the distribution of pharmaceutical products, medical equipment, and consumer products. The company divides its business into two segments that contribute to the company's operating revenues, namely Pharmaceutical Products and Consumer Products. It generates the majority of the revenue from the Pharmaceutical Products segment. Pharmaceutical Segment a special segment for distributing pharmaceutical products or medicines and medical devices. Geographically, the company operates in Java and Outside Java, of which derives maximum revenue from Java.
15GF Score
Get the complete analysis for ISX:PEVE
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PEVE has been successfully added to your 
